Naofumi Hashimoto

919 total citations
36 papers, 772 citations indexed

About

Naofumi Hashimoto is a scholar working on Pharmaceutical Science, Molecular Biology and Pharmacology. According to data from OpenAlex, Naofumi Hashimoto has authored 36 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmaceutical Science, 10 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Naofumi Hashimoto's work include Drug Solubulity and Delivery Systems (16 papers), Advanced Drug Delivery Systems (9 papers) and Analytical Chemistry and Chromatography (5 papers). Naofumi Hashimoto is often cited by papers focused on Drug Solubulity and Delivery Systems (16 papers), Advanced Drug Delivery Systems (9 papers) and Analytical Chemistry and Chromatography (5 papers). Naofumi Hashimoto collaborates with scholars based in Japan, United States and Indonesia. Naofumi Hashimoto's co-authors include Kayo Yuminoki, Satomi Onoue, Shizuo Yamada, Yohei Kawabata, Hideyuki Sato, Takahiro Mizumoto, Hiroki Suzuki, Yoshiaki Uchida, Kumiko Ogawa and Tatsuya Nakamura and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Naofumi Hashimoto

36 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naofumi Hashimoto Japan 16 388 194 119 85 81 36 772
Phuong Tran South Korea 15 382 1.0× 237 1.2× 141 1.2× 44 0.5× 154 1.9× 35 912
Harinath N. More India 19 341 0.9× 227 1.2× 79 0.7× 61 0.7× 136 1.7× 97 998
Song Hong-tao China 16 210 0.5× 248 1.3× 170 1.4× 37 0.4× 46 0.6× 56 859
Subhashis Chakraborty India 12 618 1.6× 299 1.5× 101 0.8× 76 0.9× 72 0.9× 21 1.2k
Mohd Aftab Alam Saudi Arabia 15 478 1.2× 224 1.2× 173 1.5× 23 0.3× 70 0.9× 48 1.1k
Muddana Eswara Bhanoji Rao India 17 462 1.2× 124 0.6× 74 0.6× 33 0.4× 97 1.2× 49 743
Rajneet Kaur Khurana India 19 329 0.8× 230 1.2× 96 0.8× 30 0.4× 198 2.4× 32 1.1k
Mihir Raval India 18 498 1.3× 147 0.8× 186 1.6× 64 0.8× 128 1.6× 43 875
Karimunnisa S. Shaikh India 15 293 0.8× 181 0.9× 54 0.5× 30 0.4× 153 1.9× 26 678
Raju Jukanti India 17 816 2.1× 212 1.1× 160 1.3× 28 0.3× 104 1.3× 44 1.1k

Countries citing papers authored by Naofumi Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Naofumi Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naofumi Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naofumi Hashimoto more than expected).

Fields of papers citing papers by Naofumi Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naofumi Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naofumi Hashimoto. The network helps show where Naofumi Hashimoto may publish in the future.

Co-authorship network of co-authors of Naofumi Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Naofumi Hashimoto. A scholar is included among the top collaborators of Naofumi Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naofumi Hashimoto. Naofumi Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Hiroki, Kouki Kato, Kayo Yuminoki, et al.. (2018). Enhanced biopharmaceutical effects of tranilast on experimental colitis model with use of self-micellizing solid dispersion technology. International Journal of Pharmaceutics. 545(1-2). 19–26. 9 indexed citations
2.
Suzuki, Hiroki, Kayo Yuminoki, Naofumi Hashimoto, et al.. (2016). Development of a novel nanoparticle formulation of thymoquinone with a cold wet-milling system and its pharmacokinetic analysis. International Journal of Pharmaceutics. 511(1). 455–461. 10 indexed citations
3.
4.
Suzuki, Hiroki, et al.. (2015). Strategic application of self-micellizing solid dispersion technology to respirable powder formulation of tranilast for improved therapeutic potential. International Journal of Pharmaceutics. 499(1-2). 255–262. 8 indexed citations
5.
Onoue, Satomi, Hiroki Suzuki, Hideyuki Sato, et al.. (2014). Self-micellizing solid dispersion of cyclosporine A with improved dissolution and oral bioavailability. European Journal of Pharmaceutical Sciences. 62. 16–22. 42 indexed citations
6.
Yuminoki, Kayo, et al.. (2014). Preparation and Evaluation of High Dispersion Stable Nanocrystal Formulation of Poorly Water‐Soluble Compounds by Using Povacoat. Journal of Pharmaceutical Sciences. 103(11). 3772–3781. 15 indexed citations
7.
Onoue, Satomi, Hiroki Suzuki, Kayo Yuminoki, et al.. (2013). Development of novel solid dispersion of tranilast using amphiphilic block copolymer for improved oral bioavailability. International Journal of Pharmaceutics. 452(1-2). 220–226. 40 indexed citations
8.
Onoue, Satomi, Tatsuya Nakamura, Yoshiaki Uchida, et al.. (2013). Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects. European Journal of Pharmaceutical Sciences. 49(4). 453–460. 53 indexed citations
9.
Onoue, Satomi, et al.. (2013). Biopharmaceutical characterization of nanocrystalline solid dispersion of coenzyme Q10 prepared with cold wet-milling system. European Journal of Pharmaceutical Sciences. 53. 118–125. 39 indexed citations
10.
Sato, Hideyuki, Yohei Kawabata, Kayo Yuminoki, et al.. (2012). Comparative studies on physicochemical stability of cyclosporine A-loaded amorphous solid dispersions. International Journal of Pharmaceutics. 426(1-2). 302–306. 20 indexed citations
11.
Onoue, Satomi, Yoshiaki Uchida, Haruki Takahashi, et al.. (2011). Development of High-Energy Amorphous Solid Dispersion of Nanosized Nobiletin, a Citrus Polymethoxylated Flavone, with Improved Oral Bioavailability. Journal of Pharmaceutical Sciences. 100(9). 3793–3801. 60 indexed citations
12.
Onoue, Satomi, Hideyuki Sato, Kumiko Ogawa, et al.. (2010). Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach. International Journal of Pharmaceutics. 399(1-2). 94–101. 77 indexed citations
13.
Onoue, Satomi, Hideyuki Sato, Yohei Kawabata, et al.. (2009). In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy. Journal of Controlled Release. 138(1). 16–23. 59 indexed citations
14.
Niwa, Toshiyuki & Naofumi Hashimoto. (2007). Novel technology to prepare oral formulations for preclinical safety studies. International Journal of Pharmaceutics. 350(1-2). 70–78. 13 indexed citations
15.
Ono, Junko, Kenichi Sugita, Toshihiro Fujioka, et al.. (1999). Development of Anti-Influenza Virus Drugs I: Improvement of Oral Absorption and In Vivo Anti-Influenza Activity of Stachyflin and Its Derivatives. Pharmaceutical Research. 16(7). 1041–1046. 22 indexed citations
16.
Hashimoto, Naofumi & Koichiro Hirano. (1998). Isomerization of Ceftibuten in Aqueous Solution. Journal of Pharmaceutical Sciences. 87(9). 1091–1096. 2 indexed citations
17.
Muranushi, Noriyuki, Naofumi Hashimoto, & Koichiro Hirano. (1995). Transport Characteristics of S-1090, A New Oral Cephem, in Rat Intestinal Brush-Border Membrane Vesicles. Pharmaceutical Research. 12(10). 1488–1492. 5 indexed citations
18.
Hashimoto, Naofumi, Toshihiro Fujioka, Kunio Hayashi, et al.. (1994). Renin Inhibitor: Relationship Between Molecular Structure and Oral Absorption. Pharmaceutical Research. 11(10). 1443–1447. 8 indexed citations
19.
Hashimoto, Naofumi, et al.. (1990). Epimerization Kinetics of Moxalactam in Frozen Urine and Plasma Samples. Pharmaceutical Research. 7(4). 364–369. 4 indexed citations
20.
Hashimoto, Naofumi, et al.. (1988). Epimerization Kinetics of Moxalactam in Frozen Solution. Pharmaceutical Research. 5(5). 266–271. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phuong Tran Breakdown of academic impact, for papers by Harinath N. More Breakdown of academic impact, for papers by Song Hong-tao Breakdown of academic impact, for papers by Subhashis Chakraborty Breakdown of academic impact, for papers by Mohd Aftab Alam Breakdown of academic impact, for papers by Muddana Eswara Bhanoji Rao Breakdown of academic impact, for papers by Rajneet Kaur Khurana Breakdown of academic impact, for papers by Mihir Raval Breakdown of academic impact, for papers by Karimunnisa S. Shaikh Breakdown of academic impact, for papers by Raju Jukanti
Rankless by CCL
2026